• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dyrk1A 介导的早老素 1 磷酸化:唐氏综合征与阿尔茨海默病之间的功能联系。

Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease.

机构信息

Graduate Program in Neuroscience, Institute for Brain Science and Technology (IBST), Inje University, Busan, South Korea.

出版信息

J Neurochem. 2010 Nov;115(3):574-84. doi: 10.1111/j.1471-4159.2010.06769.x. Epub 2010 Aug 19.

DOI:10.1111/j.1471-4159.2010.06769.x
PMID:20456003
Abstract

The dual-specificity tyrosine(Y)-phosphorylation-regulated kinase 1A (Dyrk1A) gene is located on human chromosome 21 and encodes a proline-directed protein kinase that might be responsible for mental retardation and early onset of Alzheimer's disease (AD) in Down syndrome (DS) patients. Presenilin 1 (PS1) is a key component of the γ-secretase complex in the generation of β-amyloid (Aβ), an important trigger protein in the pathogenesis of AD. Increased Dyrk1A expression has been reported in human AD and DS brains. We previously showed that Dyrk1A increased Aβ production in mammalian cells and transgenic mice that over-express Dyrk1A. In this study, we describe a potential mechanism by which Aβ is increased in Dyrk1A-over-expressing DS and AD brains. First, we show that PS1 is phosphorylated by the Dyrk1A at Thr(354) and that this phosphorylation increases γ-secretase activity. Then, using transgenic mice that over-express human Dyrk1A, we demonstrate that phospho-Thr354-PS1 (pT354-PS1) expression is enhanced when Dyrk1A level is increased. We also show that pT354-PS1 is more stable than the unphosphorylated form of PS1. These results reveal a potential regulatory link between Dyrk1A and PS1 in the Aβ pathway of DS and AD brains, suggesting that up-regulated Dyrk1A may accelerate AD pathogenesis through PS1 phosphorylation.

摘要

双特异性酪氨酸(Y)-磷酸化调节激酶 1A (Dyrk1A) 基因位于人类染色体 21 上,编码一种脯氨酸定向蛋白激酶,可能导致唐氏综合征 (DS) 患者的智力迟钝和早发性阿尔茨海默病 (AD)。早老素 1 (PS1) 是 γ-分泌酶复合物的关键组成部分,在β-淀粉样蛋白 (Aβ) 的产生中起重要作用,Aβ 是 AD 发病机制中的重要触发蛋白。在人类 AD 和 DS 大脑中,Dyrk1A 的表达增加已被报道。我们之前表明,Dyrk1A 增加了哺乳动物细胞和过度表达 Dyrk1A 的转基因小鼠中 Aβ 的产生。在这项研究中,我们描述了 Dyrk1A 过度表达的 DS 和 AD 大脑中 Aβ 增加的潜在机制。首先,我们表明 Dyrk1A 在 Thr(354)处磷酸化 PS1,并且这种磷酸化增加了 γ-分泌酶活性。然后,使用过度表达人 Dyrk1A 的转基因小鼠,我们证明当 Dyrk1A 水平增加时,磷酸化 Thr354-PS1(pT354-PS1) 的表达增强。我们还表明,pT354-PS1 比未磷酸化形式的 PS1 更稳定。这些结果揭示了 Dyrk1A 和 PS1 在 DS 和 AD 大脑的 Aβ 途径中的潜在调节联系,表明上调的 Dyrk1A 可能通过 PS1 磷酸化加速 AD 的发病机制。

相似文献

1
Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease.Dyrk1A 介导的早老素 1 磷酸化:唐氏综合征与阿尔茨海默病之间的功能联系。
J Neurochem. 2010 Nov;115(3):574-84. doi: 10.1111/j.1471-4159.2010.06769.x. Epub 2010 Aug 19.
2
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.双特异性酪氨酸(Y)磷酸化调节激酶1A介导的淀粉样前体蛋白磷酸化:唐氏综合征与阿尔茨海默病之间功能联系的证据。
J Neurochem. 2008 Mar;104(5):1333-44. doi: 10.1111/j.1471-4159.2007.05075.x. Epub 2007 Nov 14.
3
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.组成型Dyrk1A在阿尔茨海默病、唐氏综合征、皮克病及相关转基因模型中异常表达。
Neurobiol Dis. 2005 Nov;20(2):392-400. doi: 10.1016/j.nbd.2005.03.020.
4
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.DYRK1A基因位于21号染色体唐氏综合征关键区域,在阿尔茨海默病中连接β-淀粉样蛋白生成与tau蛋白磷酸化过程。
Hum Mol Genet. 2007 Jan 1;16(1):15-23. doi: 10.1093/hmg/ddl437. Epub 2006 Nov 29.
5
A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.一种用于治疗阿尔茨海默病的新型DYRK1A(双重特异性酪氨酸磷酸化调节激酶1A)抑制剂:体外对Tau蛋白和淀粉样病变的影响
J Neurochem. 2015 May;133(3):440-51. doi: 10.1111/jnc.13018. Epub 2015 Jan 26.
6
Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.在唐氏综合征来源的成纤维细胞中,中性内肽酶被双特异性酪氨酸磷酸化调节激酶1A(DYRK1A)抑制。
Biol Pharm Bull. 2017;40(3):327-333. doi: 10.1248/bpb.b16-00825.
7
[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].[阐明唐氏综合征患者早发性阿尔茨海默病的致病机制]
Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2.
8
Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome.永生海马细胞中Dyrk1A的过表达产生唐氏综合征的神经病理学特征。
Mol Cell Neurosci. 2007 Oct;36(2):270-9. doi: 10.1016/j.mcn.2007.07.007. Epub 2007 Jul 24.
9
PI3K inhibition causes the accumulation of ubiquitinated presenilin 1 without affecting the proteasome activity.PI3K 抑制导致泛素化早老素 1 的积累,而不影响蛋白酶体活性。
Biochem Biophys Res Commun. 2010 Jan 8;391(2):1240-5. doi: 10.1016/j.bbrc.2009.12.051. Epub 2009 Dec 16.
10
Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α.Dyrk1A 对 Munc18-1 的磷酸化调节其与 Syntaxin 1 和 X11α 的相互作用。
J Neurochem. 2012 Sep;122(5):1081-91. doi: 10.1111/j.1471-4159.2012.07861.x. Epub 2012 Aug 3.

引用本文的文献

1
Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease.血浆p-tau212作为散发性和唐氏综合征型阿尔茨海默病的生物标志物。
Alzheimers Dement. 2025 Apr;21(4):e70172. doi: 10.1002/alz.70172.
2
Design, synthesis, and structure-activity relationship studies of 6-benzo[]indeno[1,2-]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors.作为DYRK1A/CLK1/CLK4/组蛋白Haspin激酶抑制剂的6-苯并[]茚并[1,2-]噻吩-6-酮衍生物的设计、合成及构效关系研究
RSC Med Chem. 2024 Oct 17;16(1):179-99. doi: 10.1039/d4md00537f.
3
Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation.
探索新型 GSK-3β 抑制剂的抗神经炎症和神经保护作用:合成、晶体学、计算分析和生物学评价。
ACS Chem Neurosci. 2024 Sep 4;15(17):3181-3201. doi: 10.1021/acschemneuro.4c00365. Epub 2024 Aug 19.
4
Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer's Disease-Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors.将 GSK-3β 的抑制活性与 IKK-β 或 ROCK-1 的抑制活性相连接,以靶向阿尔茨海默病中的 Tau 聚集和神经炎症——基于噻唑的抑制剂的发现、体外和细胞内活性。
Molecules. 2024 Jun 2;29(11):2616. doi: 10.3390/molecules29112616.
5
GR/Ahi1 regulates WDR68-DYRK1A binding and mediates cognitive impairment in prenatally stressed offspring.GR/Ahi1 调节 WDR68-DYRK1A 的结合,并介导产前应激后代的认知障碍。
Cell Mol Life Sci. 2024 Jan 10;81(1):20. doi: 10.1007/s00018-023-05075-1.
6
Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A.多功能“金发姑娘”激酶DYRK1A的蛋白质相互作用领域的见解
Front Cell Dev Biol. 2023 Oct 12;11:1277537. doi: 10.3389/fcell.2023.1277537. eCollection 2023.
7
Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity.尿石素 A 通过抑制 DYRK1A 活性对阿尔茨海默病表现出神经保护作用。
J Food Drug Anal. 2023 Jun 15;31(2):358-370. doi: 10.38212/2224-6614.3462.
8
Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core.直截了当获得一类新型双重 DYRK1A/CLK1 抑制剂,其具有简单的二氢喹啉核心。
Molecules. 2022 Dec 21;28(1):36. doi: 10.3390/molecules28010036.
9
Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.2 型糖尿病与阿尔茨海默病:共同的分子机制和潜在的共同治疗靶点。
Int J Mol Sci. 2022 Dec 4;23(23):15287. doi: 10.3390/ijms232315287.
10
Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases.俄罗斯太平洋海域的海洋天然产物可作为神经退行性疾病药物的来源。
Mar Drugs. 2022 Nov 11;20(11):708. doi: 10.3390/md20110708.